Navigation Links
Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO

DA”) or European Medicines Agency
(“EMEA”);
• the safety and efficacy of the Company’s products or product candidates;
• the Company’s assessment of its clinical trials;
• the commencement and completion of clinical trials;
• the Company’s ability to develop, manufacture, license and sell its products or product
candidates;
• the Company’s ability to enter into and successfully execute license and collaborative
agreements, if any;
• the adequacy of the Company’s capital resources and cash flow projections, and the
Company’s ability to obtain sufficient financing to maintain the Company’s planned
operations;
• the adequacy of the Company’s patents and proprietary rights;
• the impact of litigation that has been brought against the Company and its officers and
directors and any proposed settlement of such litigation;
• the Company’s ability to regain compliance with the NASDAQ’s listing qualifications, or
its ability to successfully appeal the NASDAQ delisting; and
• the other risks described under Certain Risks and Uncertainties Related to the
Company’s Business, as contained in the Company’s Annual Report on Form 10-K and
Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a
number of factors that could cause actual results and developments to differ materially. For a
discussion of those risks and uncertainties, please see the Company's Annual Report on Form
10-K for 2006 and its most recent quarterly report on Form 10-Q.

CONTACT:
For Genta Incorporated
Tara Spiess/Andrea Romstad
TS Communications Group, LLC
(908) 286-3980
info@genta.c
'"/>





Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/22/2014)... 2014 ... eTMF im Jahr 2015 verdoppeln werden ... klinischen Versuchsreihen, die zunehmenden Anforderungen der Gesundheitsbehörden ... mit Informationen über ihre Versuchsreihen (Trial Master ... Die bisher größte TMF-Umfrage in der ...
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... $200 million of its common stock in an underwritten ... Merrill Lynch are acting as joint book-running managers for ... option to purchase additional shares of its common stock. ... offering are being sold by Avanir.  The offering is ...
Breaking Medicine Technology:Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 2Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 3Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 4Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 5SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... MELVILLE, N.Y., Nov. 28, 2011  Henry Schein, Inc. ... of health care products and services to office-based ... Complete™ program, a new integrated comprehensive solution that ... for the successful implementation of dental sleep medicine ...
... Medical Incorporated (OTCBB: ONCS), a biotechnology company developing ... cancer and other solid tumor cancers, today announced ... presenting at the 15th Annual Biotech and Specialty ... (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 2Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 3Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 4Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 5OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference 2
(Date:9/22/2014)... Utah (PRWEB) September 23, 2014 ... and corporate training, will be attending and exhibiting ... the American Health Information Management Association (AHIMA) in ... September 27 through October 1, and Career Step ... on its suite of coding training products, including ...
(Date:9/22/2014)... (PRWEB) September 23, 2014 The Marietta ... helping to promote National Breast Cancer Awareness Month ... contribute awareness to cause, prevention, diagnosis, treatment and cure by ... offices across the U.S. , A pink edition Philips ... that can tell us why the Sonicare is important to ...
(Date:9/22/2014)... During the annual Oregon Health Care Association ... care and senior housing industry are recognized for their ... of others. , This year, Nicolette Merino, Regional ... awarded the OHCA Special Service Award. This award is ... assist OHCA in reaching strategic objectives or help achieve ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 On ... Radio Network launched their first evening show, “KC After Dark.” ... Marcus Edwards, “KC After Dark” will air every Tuesday at ... a free iPad for the 50th caller, and because of ... well past the call in mark with 500 callers. ...
(Date:9/22/2014)... Sterling Heights, MI (PRWEB) September 22, 2014 ... will be partnering with Playworks, a local nonprofit that is ... At least 50 volunteers including UHY employees, their families and ... Americas School to help paint on cement games and graphics, ... , This outing was originally scheduled to occur in ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Verde Pointe Dental Associates Participate in Breast Cancer Awareness Month 2014 with a Pink Philips Sonicare Giveaway 2Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3
... Neuroradiologist in the Mayo clinic said that after the treatment ... ,He says that the treatment is very effective when compared ... ,He also explains that vertebroplasty is a process in ... compression fractures are present. These compressions arise due to osteoporosis. ...
... worst AIDS affected countries in the world, with an infection ... all // those who were in need of it. The ... to 110,000 people. The country is badly in need of ... entire nation will be destroyed socially and economically. ...
... might be using "substandard poultry vaccine", which could be the ... flu //in that country. ,Dr Robert Webster, ... that this problem was not confined to mainland China alone. ... vaccines. I think there are substandard vaccines for influenza in ...
... woman in Gopinathpur village after she underwent a family planning ... panic and confusion in the Kendrapara district. // ... been operated (tubectomy) as a part of the health camp, ... husband, Sudarshan, Jayanti had complaints of severe abdominal pain after ...
... validated from Medicare data as Medicare covers more than 40 ... be known from these data // reports Professor Richard Platt, ... useful for knowing the true benefits of the drug and ... the data obtained from Medicare would be far better than ...
... molecular link between the type 2 diabetes onset and ... fat. // This is because of the disruption in ... according to a recent research. According to the researchers, ... glycosyltransferase (GnT-4a) disrupts insulin production. ,The experiments ...
Cached Medicine News:Health News:Improved cure and activity level seen among patients treated by Vertebroplasty. 2Health News:Botswana Continues Its Fight Against AIDS 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: